Literature DB >> 26955898

Actinic keratosis: correlation between clinical and histological classification systems.

L Schmitz1,2, P Kahl3, M Majores3, E Bierhoff3, E Stockfleth1, T Dirschka2,4.   

Abstract

BACKGROUND: There are several clinical and histological classification systems for grading actinic keratosis (AK) lesions. The Olsen clinical classification scheme grades AK lesions according to their thickness and degree of hyperkeratosis (grades 1-3). The Roewert-Huber histological classification system grades AK lesions based on the extent of epidermal atypical keratinocytes (AK I-III).
OBJECTIVE: The aim of this study was to determine whether there is a correlation between these clinical and histological AK classification schemes.
METHODS: One AK lesion from patients in three pivotal clinical studies and routine practice was assessed clinically and histologically. A match in grading was defined as Olsen grade 1 being classified histologically as AK I, Olsen grade 2 as AK II and Olsen grade 3 as AK III.
RESULTS: Of the 892 lesions included, 29.0% were classified as Olsen grade 1, 59.6% as Olsen grade 2 and 11.3% as Olsen grade 3; 19.2% were histologically classified as AK I, 69.6% as AK II and 11.2% as AK III. Only 480 lesions (53.8%) had a matching clinical and histological classification. Of these matches, most were 'Olsen grade 2 = AK II' (83.1%). The Spearman's rank correlation coefficient for clinical and histological classification was r = 0.0499 (P = 0.137).
CONCLUSIONS: Clinical classification of AK lesions using the system of Olsen does not accurately match histological classification of the same lesions using the system of Roewert-Huber. Consequently, it is not possible to draw conclusions about the histology of AK lesions from their clinical appearance. This finding reinforces the need to treat all AK lesions as well as field cancerization.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 26955898     DOI: 10.1111/jdv.13626

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  13 in total

1.  Attitudes among dermatologists regarding actinic keratosis treatment options.

Authors:  Gaia Moretta; Tonia Samela; Francesca Sampogna; Francesco Ricci; Fabio Carlesimo; Annarita Panebianco; Angelo Massimiliano D'Erme; Giovanni Di Lella; Sabatino Pallotta; Elena Dellambra; Damiano Abeni; Luca Fania
Journal:  Dermatol Reports       Date:  2022-01-31

2.  T-Cadherin Expression in Actinic Keratosis Transforming to Invasive Squamous Cell Carcinoma.

Authors:  Stanislaw A Buechner; Therese J Resink
Journal:  Dermatopathology (Basel)       Date:  2019-01-10

Review 3.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

Review 4.  Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches.

Authors:  Zoe Apalla; Dorothée Nashan; Richard B Weller; Xavier Castellsagué
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-01

5.  A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions.

Authors:  Maria Pia De Padova; Barbara Marzani; Daniela Pinto; Fabio Rinaldi
Journal:  Dermatol Ther (Heidelb)       Date:  2018-07-27

6.  Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate.

Authors:  Ricardo Moreno; Laura Nájera; Marta Mascaraque; Ángeles Juarranz; Salvador González; Yolanda Gilaberte
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

Review 7.  Daylight Photodynamic Therapy: An Update.

Authors:  Chaw-Ning Lee; Rosie Hsu; Hsuan Chen; Tak-Wah Wong
Journal:  Molecules       Date:  2020-11-08       Impact factor: 4.411

8.  5-Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12-month follow-up study on 21 patients.

Authors:  S Radakovic; M Dangl; A Tanew
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-10       Impact factor: 6.166

9.  Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression.

Authors:  Ida M Heerfordt; Christoffer V Nissen; Thomas Poulsen; Peter A Philipsen; Hans Christian Wulf
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

Review 10.  A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.

Authors:  Robert Sinclair; Christopher Baker; Lynda Spelman; Madeleine Supranowicz; Beth MacMahon
Journal:  Australas J Dermatol       Date:  2020-08-25       Impact factor: 2.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.